Back to shop

Blend · Research use only

CagriSema (Cagrilintide + Semaglutide)

$159CAD

A blend of the amylin analogue cagrilintide and the GLP-1 receptor agonist semaglutide (5mg each), explored in metabolic research.

Available to approved purchasers

Select strength
1
Documentation review pending Fulfilled in Canada Research use only

Can’t find the right record?Send support the product name or batch code.

Contact support
CagriSema (Cagrilintide + Semaglutide)$159

Product information

CagriSema (Cagrilintide + Semaglutide), clearly explained.

A blend of the amylin analogue cagrilintide and the GLP-1 receptor agonist semaglutide (5mg each), explored in metabolic research.

Overview

The combination has been evaluated in large clinical trials as a sponsor-manufactured product and is not approved in Canada. Those results do not establish the safety or performance of a separately prepared research blend.

Format
Vial
Available strengths
10mg
Documentation
Source review pending

Specifications

Product details

Storage and handling
Store lyophilized material according to the conditions on the batch record. Protect from light and moisture.
Batch documentationSource review pending

Supplier-origin documentation will be published only after EternaGen verifies the source and record details.

Not yet published